Pecoss Healthcare

Formoterol Fumarate and Fluticasone Rotacaps are a combination medication for the maintenance treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD), containing the long-acting bronchodilator formoterol to open airways and the inhaled corticosteroid fluticasone to reduce airway inflammation. They are not for immediate relief of sudden attacks and require rinsing the mouth after use to prevent fungal infections. This is a prescription medicine to be used as directed by a doctor and should not be stopped abruptly.

Salmeterol 50mcg/Fluticasone 500mcg Rotacaps contain a combination of a long-acting beta-agonist (LABA), salmeterol, which relaxes airway muscles, and an inhaled corticosteroid (ICS), fluticasone, which reduces inflammation. This dual-action medication is used for the maintenance treatment of moderate to severe asthma and Chronic Obstructive Pulmonary Disease (COPD) to provide 24-hour symptom control by opening airways and reducing inflammation, thereby improving lung function and preventing exacerbations. It is not a rescue medication for acute asthma attacks. 

The combination of budesonide and formoterol is used to prevent and treat difficulty breathing, wheezing, shortness of breath, coughing, and chest tightness caused by asthma in adults and children 6 years of age and older.